Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! DANBURY, Conn., July 3, 2013 -- Biodel Inc. announced today that management will present new preclinical pharmacokinetic and pharmacodynamic data on its glucagon formulation intended for use in a novel auto-reconstitution device.
via Danbury Newswire http://www.biospace.com/news_story.aspx?StoryID=301852&full=1
via Danbury Newswire http://www.biospace.com/news_story.aspx?StoryID=301852&full=1
No comments:
Post a Comment